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Analysis of Polyubiquitin Conjugates Reveals
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Proteasome Targets*□S
Thibault Mayor, J. Russell Lipford, Johannes Graumann, Geoffrey T. Smith,
and Raymond J. Deshaies‡
The polyubiquitin receptor Rpn10 targets ubiquitylated
Sic1 to the 26S proteasome for degradation. In contrast,
turnover of at least one ubiquitin-proteasome system
(UPS) substrate, CPY*, is impervious to deletion of RPN10.
To distinguish whether RPN10 is involved in the turnover
of only a small set of cell cycle regulators that includes
Sic1 or plays a more general role in the UPS, we sought to
develop a general method that would allow us to survey
the spectrum of ubiquitylated proteins that selectively
accumulate in rpn10 cells. Polyubiquitin conjugates from
yeast cells that express hexahistidine-tagged ubiquitin (H6-
ubiquitin) were first enriched on a polyubiquitin binding pro-
tein affinity resin. This material was then denatured and
subjected to IMAC to retrieve H6-ubiquitin and proteins to
which it may be covalently linked. Using this approach, we
identified 127 proteins that are candidate substrates for the
26S proteasome. We then sequenced ubiquitin conjugates
from cells lacking Rpn10 (rpn10) and identified 54 proteins
that were uniquely recovered from rpn10 cells. These in-
clude two known targets of the UPS, the cell cycle regulator
Sic1 and the transcriptional activator Gcn4. Our approach
of comparing the ubiquitin conjugate proteome in wild-type
andmutant cells has the resolving power to identify even an
extremely inabundant transcriptional regulatory protein and
should be generally applicable to mapping enzyme sub-
strate networks in the UPS. Molecular & Cellular Pro-
teomics 4:741–751, 2005.
In eukaryotic cells, protein degradation plays a critical role
in the regulation of a variety of cellular processes including the
cell cycle, apoptosis, signal transduction, and gene expres-
sion. The ubiquitin-proteasome system (UPS)1 is the principal
pathway that targets proteins for degradation. In this path-
way, proteins to be degraded are marked by covalent modi-
fication of a lysine residue with an ubiquitin chain. The enzy-
matic reaction (ubiquitylation) is driven by an ubiquitin-
activating enzyme E1, ubiquitin-conjugating enzyme E2, and
ubiquitin-ligase E3 (1). The substrate conjugated to the ubiq-
uitin chain is then recognized by the 26S proteasome and
degraded. The exquisite specificity of substrate recognition
for ubiquitylation is thought to be determined primarily by E3,
which binds specifically to substrate (2, 3). The budding yeast
genome encodes about 50 putative ubiquitin-ligases,2
whereas metazoans may have more than 400 (4). Because
each ubiquitin-ligase presumably can target several sub-
strates, ubiquitylation represents one of the main post-trans-
lational modifications in the cell. Therefore, deciphering the
network of enzyme-target interactions in the UPS will be a
major undertaking.
To be recognized by the proteasome, a substrate-linked
ubiquitin chain must assemble through lysine 48 (Lys48) of
ubiquitin (5). By contrast, mono-ubiquitin linkages and mul-
tiubiquitin chains linked via the alternative lysine 63 (Lys63) of
ubiquitin regulate multiple pathways by nonproteolytic means,
including DNA repair (6), chromatin topology, and vesicle
trafficking (7). In the past few years, several proteins that
recognize specifically Lys48-linked chains have been identi-
fied. Rpn10, a stoichiometric component of the 26S protea-
some, was the first protein shown to bind polyubiquitin chains
(8). Rpn10 harbors two characterized domains: the amino-
terminal von Willebrand A (VWA) domain that mediates pro-
teasome association and the carboxyl-terminal ubiquitin-in-
teracting motif (UIM) domain. The UIM is also present in other
proteins involved in the ubiquitin pathway and endocytosis
(9). Based on its ability to bind to the proteasome and to
ubiquitylated proteins, Rpn10 was predicted to be the major
proteasome receptor for ubiquitylated substrates. However,
deletion of RPN10 in budding yeast is not lethal, indicating
that other proteins must act as proteasome receptors (10).
Rad23 and Dsk2 belong to a second group of proteins that
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interacts with the proteasome via an amino-terminal ubiquitin-
like domain and contain a carboxyl-terminal polyubiquitin
binding motif, the ubiquitin-associated (UBA) domain. There is
evidence suggesting that both proteins can act as protea-
some receptors (11, 12). There is also other evidence that
suggests these two proteins may play an alternative role in
protecting ubiquitylated substrates from de-ubiquitylation ac-
tivity and in promoting or in inhibiting multiubiquitylation of
substrates (13–16). Whereas the physiological functions of
ubiquitin binding proteins remain to be fully elucidated, a
recent study showed that mutations in RPN10, RAD23, or
UFD1 (Ufd1 is a member of a protein complex that may also
act as a proteasome substrate receptor) selectively impair the
turnover of distinct substrates of the UPS (17). This surprising
finding implies that different targeting mechanisms are used
by the proteasome to degrade specific subsets of substrates.
Certain UPS substrates (Sic1, Clb2, and Gic2) but not others
(CPY* and the Deg1 degron of Mat2) are strongly influenced
by Rpn10 (17). This suggested that a restricted class of UPS
substrates, possibly short lived regulators of the cell cycle and
its efferent pathways, is targeted to the proteasome by
Rpn10.
Here, we employ a new method for ubiquitin conjugate
affinity purification to identify proteins that accumulate as
ubiquitylated species in yeast cells that lack Rpn10. Our anal-
ysis greatly expands the role that Rpn10 plays in protein
turnover in vivo. By applying the approach described here, it
should be possible to systematically identify the constellation
of substrates targeted to the proteasome by each individual
receptor pathway in Saccharomyces cerevisiae.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids—All S. cerevisiae strains used in this
study are listed in supplemental Table 1. RJD2997 was generated by
integrating the plasmid RDB1848, which contains the coding se-
quences for H6-ubiquitin flanked by the GPD constitutive promoter
and PGK terminator sequences (18), into the TRP1 locus. Control
strain RJD2998 was obtained by integrating the empty vector into the
TRP1 locus. Mutant rpn10 was retrieved from the Yeast Deletion
Library (Open Biosystem) and back-crossed into the W303 back-
ground. Gcn4-Myc9 was previously described (19). S288C strains
with TAP-tagged genes were retrieved from the Yeast TAP-Fusion
Library (Open Biosystem).
The H8-ubiquitin coding sequence was placed between the GPD
constitutive promoter and PGK terminator sequences in pRS316
(RDB1851). A pair of primers (5-GCGGATCCATGAGAGGTAGTCAC-
CACCATCATCACCATCATCACGGTGGTATGCAGATTTTCG-3 and
5-GAGCTCGAGACCACCTCTTAGCCTTAGCAC-3) was used to
amplify by PCR yeast ubiquitin (the first repeat of the UBI4 locus). The
PCR fragment was digested with BamHI and XhoI and ligated into the
yeast expression vector pG-1 (20) (digested with BamHI and SalI). An
EcoRI-NaeI fragment containing H8-ubiquitin was then ligated into
pRS316 (digested with EcoRI and SmaI).
Immobilization of Polyubiquitin Binding Proteins—GST-Rad23 and
GST-Dsk2 were generous gifts from H. Kobayashi and H. Yokosawa,
respectively. Fusion proteins were expressed in BL21(DE3)/pLysS
and purified using glutathione-Sepharose resin. Ten mg of GST-
Dsk2p and 20 mg of GST-Rad23 were separately coupled to 1.5 ml of
resin volume of CNBr-activated Sepharose 4B (Amersham Bio-
sciences) in 100 mM NaHCO3, pH 8.3, 0.5 M NaCl. Coupled resin was
stored at 4 °C in a 50% slurry with 100 mM Tris-HCl, pH 8.0, 0.5 M
NaCl, 0.02% NaN3.
Two-step Purification—Cells were grown in 6 liters of YPD medium
(2% peptone, 1% yeast extract, 2% dextrose) at 25 °C to an A600 of
1.5. Cells were washed with 1/6 volume of ice-cold TBS followed by
1/30 volume of ice-cold TBS with 1 mM 1,10-phenanthroline, 10 mM
iodoacetamide. Cells were lysed using a One Shot Cell Disrupter
(Constant Systems) at 30,000 psi in 40 ml of lysis buffer (300 mM
NaCl, 0.5% Triton X-100, 50 mM sodium phosphate, pH 8.0, 0.5 mM
AEBSF, 5 g/ml aprotinin, 5 g/ml chymostatin, 5 g/ml leupeptin, 1
g/ml pepstatin A, 1 mM 1,10-phenanthroline, 10 mM iodoacetamide).
Lysate (typically 1.5 g of protein) was cleared by centrifugation at 4 °C
in a Sorvall SS34 for 20 min at 14,000 rpm. Two milligrams each of
GST-Rad23 and GST-Dsk2 coupled to Sepharose (pre-equilibrated
with lysis buffer) were added to the clarified lysate and mixed for 90
min at 4 °C. The resin was then washed with 40 ml of lysis buffer,
further mixed for 15 min with 20 ml of 50 mM sodium phosphate, pH
8.0, 2 M NaCl, and washed once with 20 ml of 50 mM sodium
phosphate, pH 8.0, 2 M NaCl and twice with 20 ml of 50 mM sodium
phosphate, pH 8.0, 300 mM NaCl, 0.1% Triton X-100. Elution was
performed at room temperature with two successive incubations with
1 ml of urea buffer (UB: 8 M urea, 100 mM NaH2PO4, 10 mM Tris-HCl,
pH 8.0), and imidazole was added to a final concentration of 20 mM.
Eluate was then mixed with 125 l of nickel magnetic bead slurry
(Promega V8565, prewashed in the UB) for 60 min on a rotating
wheel. The beads were washed with 1 ml of UB and mixed for 15 min
with UB supplemented with 0.5% SDS. The beads were then washed
with 1 ml of UB with 0.5% Triton X-100 and mixed for 15 min with
another 1 ml of UB with 0.5% Triton X-100. The last procedure was
repeated using UB only.
To generate peptides for MS-based sequencing, we performed the
tryptic digest directly on the beads. The beads were incubated with
500 l of UB with 3 mM Tris-(2-carboxyethyl)phosphine (T-CEP) for 20
min and then for another 15 min following addition of iodoacetimide to
11 mM. The buffer volume was reduced to 75 l by removing excess
liquid, and 0.2 g of endoproteinase Lys-C (Roche) was added.
Beads were incubated at 37 °C with intermittent shaking for 5 h.
Dilution buffer (225 l of 100 mM Tris-HCl, pH 8.0, 1.33 mM CaCl2)
was then added followed by 1 g of trypsin (Roche Applied Science),
and the beads were further incubated with intermittent shaking for
16 h at 37 °C. The supernatant was carefully collected, and formic
acid was added to a final concentration of 5%.
MS and Data Analysis—The proteolytically digested sample was
further processed for multidimensional chromatography coupled in-
line to ESI-MS as described previously (21). As a variation to the
chromatography program, samples were stepped off the strong cat-
ion exchanger phase of the triphasic column using 12.5, 20, 30, 40,
and 100% buffer C (500 mM ammonium acetate, 5% ACN, 0.1%
formic acid). Centroided fragmentation spectra acquired by Xcalibur
1.3 (ThermoElectron) were evaluated for spectrum quality and charge
state using 2to3 (22) and searched against the translated open read-
ing frames of the Saccharomyces Genome Database (SGD (23); re-
lease time stamp: 07/26/2004; 6,860 entries) with Sequest (version
27, revision 9; Ref. 24) utilizing unified input and output files (25).
Relevant Sequest parameters used were: (i) peptide mass tolerance
of 3.0 amu, (ii) parent ion masses were treated as monoisotopic, (iii)
fragmentation ion masses were treated as averaged, and (iv) a 57.0-
amu static modification on cysteines accounted for alkylation. Se-
quest results were filtered using DTASelect 1.9 and Contrast (26) with
the following requirements for peptide and locus identifications con-
sidered valid: minimum Xcorrs of 1.8, 2.5, and 3.5 for singly, doubly,
and triply charged ions, respectively; a minimum Cn of 0.08; and a
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minimum of two valid peptides per locus.
Small Scale Cell Extraction, IMAC, and Western Blotting—For di-
rect comparison of protein level in wild-type and rpn10 strains,
S288C cells were grown in YPD at 25 °C until an A600 of 0.5–1 was
reached. An amount of yeast cells corresponding to 4–5 A600 was
collected, briefly washed with 1 ml of 1 TBS, and frozen in liquid
nitrogen. Cells were directly resuspended in prewarmed sample
buffer, incubated for 2 min at 96 °C, lysed with glass beads in a
FastPrep 120 (Thermo Savant) for 45 s with a speed setting of 5.5,
and incubated for another 4 min at 96 °C. For IMAC purification of
H8-ubiquitin, cells transformed with a URA3-based plasmid coding
for H8-ubiquitin were grown in 100 ml of SD-URA medium (0.67%
yeast nitrogen base, 5% dextrose) at 30 °C to an A600 of 1. TCA (20%
final) was added directly to the cell culture, and cells were incubated
for 10 min on ice and washed with ice-cold 100 mM Tris-HCl (once
with pH 8.5, twice with pH 8.0). Cells were resuspended in 0.6 ml of
0.2% SDS, 8 M urea, 100 mM Hepes, pH 8.0, 1 mM 1,10-phenanthro-
line, 5 mM N-ethylmaleimide (NEM), 0.5 mM AEBSF, 5 g/ml aprotinin,
5 g/ml chymostatin, 5 g/ml leupeptin, 1 g/ml pepstatin A, and
lysed by agitation with glass beads in a FastPrep 120. Glass beads
were further washed with 0.6 ml of lysis buffer without SDS, and
lysate (containing 0.1% SDS) was cleared 10 min at 14,000 rpm in a
microcentrifuge. Imidazole (20 mM final) and nickel magnetic beads
(70 l) were added to 8.5 mg of lysate protein and mixed for 1 h at
room temperature. Beads were then washed three times in 0.1%
SDS, 8 M urea, 100 mM Hepes, pH 8.0, and proteins were eluted in
SDS-PAGE sample buffer supplemented with 1 M imidazole, 4 M urea,
50 mM Hepes, pH 8.0. TAP-tagged proteins were detected using the
anti-calmodulin binding peptide antibody (Upstate Biotechnology),
ubiquitin with MAB1510 (Chemicon International), Cdc28 with
PSTAIR antibody (Santa Cruz Biotechnology), and Gcn4-Myc9 with
9E10 monoclonal antibody.
RESULTS
Two-step Purification of Ubiquitin Conjugates—We per-
formed two-step purification of ubiquitin conjugates (Fig. 1)
from cells that express ubiquitin fused to an amino-terminal
hexahistidine tag (H6-ubiquitin), and as control we repeated
the procedure with cells that do not express H6-ubiquitin. In
both experiments, the first purification step yielded a similar
amount of proteins, whereas the IMAC only recovered appre-
ciable material from the H6-ubiquitin strain (Fig. 2A). The
signal revealed by silver staining of material fractionated by
SDS-PAGE ranged from 50 to 250 kDa and produced a
spread rather than discrete bands, as expected for a large
collection of different proteins conjugated to ubiquitin chains
of various lengths. We calculated that the first step in purifi-
cation recovered about 15% of the polyubiquitin conjugates
in the cell (Fig. 2B). Notably, mono-, di-, and triubiquitin spe-
cies were not recovered. This implies that the UBA domains of
Rad23 and Dsk2 were only enriching for proteins conjugated
to ubiquitin chains that contained more than three ubiquitins.
Because a tetraubiquitin chain is thought to comprise the
minimal signal for targeting substrates to the proteasome for
degradation (27, 28), the UBA affinity step appears to enrich
specifically for those ubiquitin conjugates that are protea-
some substrates. In the second step, the majority of the
ubiquitin conjugates (80%) eluted from the first resin were
recovered (Fig. 2C). In this experiment, only 25–30% of the
bound material was eluted with sample buffer from the nickel
beads (data not shown). Overall, our procedure resulted in a
3,000- to 5,000-fold enrichment of polyubiquitin conjugates
(1,500 mg of protein extract resulted in 30–50 g of protein,
representing 10% of the polyubiquitin in the cell).
MS Analysis—Purified proteins were directly digested on
the nickel beads, and the peptide mixture was analyzed by
multidimensional LC-MS/MS or MudPIT. Sequest and DTAS-
elect algorithms were used to analyze the spectra generated
by the complex mixture of affinity-purified proteins, and 180
nonredundant proteins were identified (supplemental Table 2).
The most abundant protein in our analysis was ubiquitin. Of a
total of 5,347 sequencing events, 457 peptides derived from
ubiquitin. This was expected because ubiquitin should be the
most prominent protein after the purification. For clarity, we
further filtered our data by removing transposon-related
genes, duplicated genes, ubiquitin fusion genes, and Rad23
and Dsk2 that leached from the resin used in the first purifi-
cation step (data not shown). The 127 remaining proteins are
FIG. 1. Flow diagram for the two-step purification of polyubiq-
uitin conjugates. Yeast cells that constitutively express ubiquitin
modified with an amino-terminal hexahistidine tag are lysed in non-
denaturing buffer (1). Polyubiquitin chains are purified using matrices
derivatized with the recombinant UBA domain-containing proteins
Rad23 and Dsk2. UBA domains bind tightly to multiubiquitin chains,
with a preference for chains linked via lysine 48 of ubiquitin (11, 49).
Contaminant proteins are removed by washes with 2 M NaCl (2), and
specifically bound proteins are then eluted in 8 M urea (3) and mixed
with nickel magnetic beads (4). In this second purification step, strin-
gent washing conditions (0.5% SDS) are used to remove contami-
nants. Trypsin is then applied directly to the beads (5), and peptides
released from the beads are analyzed by LC/LC-MS/MS (6).
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listed in Table I. We classified these proteins in different
categories according to their function (Fig. 3A). The majority of
identified proteins is involved in metabolism and translation.
Several proteins are components of regulated pathways, and
several were previously shown to be targets for degradation.
These include Ole1, a short lived protein (29), Rpo21, which is
ubiquitylated by Rsp5 (30), and Gdh1 and Mdh2, which were
shown previously to be targeted for proteolysis (31, 32). More-
over, the list includes proteins for which ubiquitylation sites
were previously identified; 14 of our 127 proteins were among
the 71 identified in the initial global study of ubiquitylated
proteins (33), and 8 of our 127 proteins were among the 33
found in a screen for membrane-associated ubiquitylated pro-
teins (34). Thus, although we identified only 2% of the yeast
proteome (127/6,000), these proteins accounted for 21% of
the ubiquitylated proteins identified by Gygi and co-workers
(33, 34), a 10-fold enrichment.
Because our ultimate goal was to compare the pool of
ubiquitylated proteins in wild-type and rpn10 cells, it was
important to assess the variability of the MS analysis. The
sample from the two-step purification described above had
been split in half after the trypsin digest but prior to the MS
analysis. When the second half of the sample was analyzed,
we identified 176 proteins (supplemental Table 3). The two
LC/LC-MS/MS analyses of the same sample were then com-
pared using the Contrast algorithm (Fig. 3B). More than 80%
of the proteins identified in one analysis were found in the
other analysis. We noticed that the variability was accounted
for mainly by proteins identified by two peptides (as the loss
of one peptide identification for a particular protein led to its
exclusion from the analysis). When we also took into account
proteins identified by only one peptide, 95% of proteins
identified by two peptides in either dataset were also identi-
fied by at least one peptide in the duplicate analysis (Fig. 3B).
This indicated that there was some variation in the data anal-
ysis, albeit tolerable, arising from either the HPLC or mass
spectrometer. Moreover, proteins defined by our minimum
cutoff of two peptides (and thus possibly of low abundance in
the purified sample) were disproportionately susceptible to
being overlooked. Because many potential targets of interest
might be in the inabundant category, we decided to perform
our subsequent analyses in triplicate to ensure the identifica-
tion of a maximum number of ubiquitin conjugates.
Impact of the Proteasome Substrate Receptor Rpn10 on
the Pool of Ubiquitin Conjugates—Our key motivation for
developing proteomic methods to identify ubiquitin conju-
gates on a global scale was to use the method to identify
substrates/targets for ubiquitin ligase and isopeptidase en-
zymes and other specificity determining factors in the UPS. In
particular, we sought to determine the breadth of the impact
of Rpn10 on ubiquitin-dependent proteolysis. We reasoned
that deletion of RPN10 would prevent the degradation of
FIG. 2. Two-step affinity purification specifically enriches for polyubiquitylated proteins. A, SDS-PAGE analysis of the two-step
purification. Purifications were performed using the H6-ubiquitin-expressing strain or the wild-type control strain that lacks tagged ubiquitin.
Aliquots of total cell extract, proteins eluted after the first step (UBA affinity) of the purification, and proteins from the second step (those bound
to the nickel magnetic beads) were separated by SDS-PAGE on a 10% polyacrylamide gel and stained with silver. Amounts loaded in
comparison to initial volumes are indicated immediately below each lane. Below that, the amount of ubiquitin conjugates for each lane (as
estimated by Western blotting, data not shown) is indicated in arbitrary units. B, immunoblotting of the first purification step. Aliquots of total
cell extract and the eluate from the UBA domain affinity step (first elution) were separated by SDS-PAGE on a 4–20% polyacrylamide gradient
gel and immunoblotted with an anti-ubiquitin antibody. The sample from the first elution is overloaded 10-fold relative to the total cell extract.
C, immunoblotting of the IMAC purification step. Equal portions of initial volumes corresponding to proteins that were eluted from the UBA
domain matrix, failed to bind the nickel-based matrix (unbound), were washed away with 0.5% SDS (SDS wash), or bound to the nickel beads
(Ni2 beads) were processed as in B.
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substrates dependent on Rpn10 for turnover. These sub-
strates would then accumulate as polyubiquitylated conju-
gates. To proceed, we collected and analyzed six independ-
ent samples; three were obtained from wild-type cells
(supplemental Tables 2 and 4) and three others from rpn10
cells (supplemental Table 5). We compared the six datasets
using the Contrast algorithm (Fig. 3C). The variability between
the different datasets (30%) was in general higher than
previously observed between two identical samples (Fig. 3B).
This was expected because it is essentially impossible to
grow cells, lyse cells, and carry out consecutive affinity puri-
fication steps in a manner that is perfectly precise. Neverthe-
less, to identify the candidate targets of Rpn10, proteins
represented in any of three rpn10 samples but not in any
RPN10 sample were extracted and rank-ordered according to
sequence coverage of the identified protein (Table II). What is
particularly noteworthy is that the second highest ranked
candidate in this subtractive screen of the entire S. cerevisiae
proteome was the cell cycle regulator Sic1, which is ubiqui-
tylated by the SCFCdc4 complex at the G1/S transition (35).
TABLE I
Proteins identified by LC/LC-MS/MS after two-step purification of ubiquitin conjugates
Name
Sequence
coverage
(%)
Peptide Name
Sequence
coverage
(%)
Peptide Name
Sequence
coverage
(%)
Peptide
SSA2a 61.5 43 RPS13 19.9 3 TDH1 9.6 3
RPL2A, B 57.1 17 RPS17A, B 19.9 2 ACT1 9.1 2
RPL21A, B 55.0 12 IML2 19.7 10 RPL34A, B 9.1 2
RPS7B 54.2 6 SRO9 19.6 4 SAN1 9.0 2
SSA1a 47.4 32 PMA1b 19.2 14 GPM1 8.9 2
RPL10 43.0 9 CIT2a 17.8 6 STI1 8.8 4
RPL3 42.9 20 GLN1a,b 17.8 6 RPT1 8.8 3
RPL15A 42.2 10 RPL4A, B 17.7 4 UBP6 8.6 5
RPS20a,b 42.1 8 ENO1 17.4 6 NOP4 8.3 4
ERG1a,b 41.7 19 PMA2 16.1 13 HSP82 7.9 7
NCE103 40.7 6 PGK1 16.1 8 UFD2 7.8 6
RPS4A, Ba 40.6 11 DRE2 16.1 5 GPD2 7.7 2
RPS7A 40.0 5 RPS8A, B 15.5 2 ACS2a 7.6 2
RPL27A, B 37.5 6 BGL2 15.3 4 OLE1 7.6 3
RPS11A, B 37.2 10 SSA4 15.1 12 FAS1 7.5 13
RPL28 36.2 10 RPS6A, B 14.8 4 HSP42 7.5 2
AAH1 36.0 10 HSP150 14.7 3 HSP104b 7.4 5
RPL19A 34.9 11 ENO2 14.6 4 RPB2 7.1 6
VMA7 34.7 2 PNG1 14.6 5 FAA4 7.1 3
RPL8A 34.4 7 RPL11B 14.4 2 YMR210W 6.7 2
TEF1, 2 34.3 9 CBR1 14.0 4 HEF3 6.6 6
RPL15B 33.8 7 TDH2 13.9 4 YOR091W 6.2 2
GDH1a 33.5 15 ADH1 13.2 4 LYS1 6.2 2
RPA190 32.5 49 YLR407W 13.1 2 PHO84a 6.1 3
RPL1A, B 31.3 5 UBC6 12.8 2 RPF2 6.1 2
RPS26A 30.3 3 URA2 12.2 20 CDC48a 5.1 3
ERG11 29.8 17 UBP3 12.1 9 FKS1b 5.0 5
RPS1A, B 29.8 7 RPT2 12.1 4 KCC4 4.9 2
RPL24A, B 29.7 7 SSA3 12.0 9 TKL1 4.9 3
TDH3 29.5 6 MLF3 11.9 3 GAS1 4.5 2
RPS18A, B 28.8 5 ERG5a 11.7 4 SNF1 4.3 2
YEF3 28.7 24 YDJ1 11.7 3 RFC1 3.5 2
RPS27A, B 28.0 2 RPS3a 11.7 2 STP2 3.3 2
SIK1 27.8 9 SAM1 11.5 2 KAR2 3.1 3
SSB1, 2 27.7 12 RPA135 11.2 7 RPO21b 2.8 4
RPL6B 26.7 6 CBF5 10.6 3 KAP123 2.7 2
RPS12 26.6 3 GDH3 10.5 7 GSC2a 2.2 2
YBR071W 25.6 4 RPN1 10.3 10 CRM1 2.2 2
RPS5 25.3 3 RPL6A 10.2 2 RET1 1.6 2
EFT2, 1 25.2 15 HSC82 10.1 8 NUM1 1.2 2
HYP2 24.8 2 RPL32 10.0 2 TIP20 1.0 2
MDH2 21.7 7 VTC4 9.8 8
RPL18A, B 21.5 5 PRE9b 9.7 2
a Ubiquitylated proteins identified by Peng et al. (33).
b Ubiquitylated proteins identified by Hitchcock et al. (34).
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We had previously shown that Sic1 degradation is substan-
tially dependent upon Rpn10 (17), suggesting that it is likely to
accumulate as a ubiquitylated species in rpn10 cells (an
assumption that was not addressed previously but has been
validated as described below). Other candidates revealed by
this substractive approach are also known to be targets for
ubiquitylation. The transcription factor Gcn4 is targeted for
proteolysis after ubiquitylation by SCFCdc4 complex (19, 36,
37), and Aro10, Ald6, Erg3, and Ecm21 were identified as
ubiquitylated proteins in a global analysis (33). Taken to-
gether, these findings suggest that our subtractive approach
was sufficiently sensitive to identify critical regulatory targets
of the UPS, even those of exceptionally low abundance such
as Gcn4, which is estimated to be present at less than 50
molecules per cell (38).
Validation of Rpn10 Targets—To evaluate the role of Rpn10
in turnover of candidate substrates identified by our MudPIT
approach, we assayed several of the proteins from Table II for
abundance and ubiquitylation. First, we compared protein
levels in RPN10 and rpn10 strains in which the endogenous
loci were modified to encode the candidate proteins with TAP
tags fused to their C termini (Fig. 4A and Table II). For several
candidates, protein levels were elevated in the rpn10 strain,
suggesting that normal turnover of these proteins was Rpn10
dependent. For Gcn4, we employed a well characterized allele
that encodes a carboxyl-terminal Myc9 tag integrated into the
GCN4 locus (19). We found that Gcn4 accumulated in rpn10
extracts, and we could also detect species migrating with a
lower mobility that correspond to polyubiquitylated Gcn4
(Fig. 4B).
In addition to inabundant proteins like Gcn4, our analysis
also identified highly abundant proteins as such the ribosomal
subunit Rpl13B. However, by Western blotting we could not
see any increase in the level of Rpl13B in rpn10 (data not
shown). We reasoned that in this case perhaps only a small
fraction of the protein pool was targeted for degradation, and
thus the overall protein abundance was not altered in rpn10.
To test this, we devised a single-step purification with nickel
beads using cells transformed with a plasmid that expressed
ubiquitin with an octahistidine tag fused to the amino terminus
(H8-ubiquitin). Purified proteins were detected with the TAP
tag antibody. An untagged rpn10 strain that expressed H8-
ubiquitin was used as a negative control and gave no signal in
the Western blot (Fig. 4C). After performing the same proce-
dure with a Sic1-TAP strain, we noticed the distinctive accu-
mulation of high molecular mass Sic1 conjugates in rpn10
but not in RPN10 cells that expressed H8-ubiquitin (Fig. 4C).
No signal was readily detected rpn10 cells not expressing
the H8-ubiquitin. Therefore, ubiquitylated Sic1 specifically ac-
cumulated in cells lacking Rpn10. Rpl13B showed similar
behavior. Although there was some nonspecific binding of
unmodified Rpl13B to the nickel beads (lower band present in
all three lanes), Rpl13B species that migrated at high molec-
ular masses (250 kDa) were exclusively detected in rpn10
cells that expressed H8-ubiquitin. Notably, species modified
with one, two, and three ubiquitins were also detected in
wild-type cells whenever H8-ubiquitin was expressed. How-
ever Rpl13B was only detected by MS in samples from
rpn10 cells. Therefore the species modified with one, two,
and three ubiquitins that were also present in RPN10 cells
FIG. 3. A, pie diagram of the identified proteins. Protein functions
retrieved from the YPD database (Incyte) were plotted according to
their representation in Table I. B, reproducibility of LC/LC-MS/MS
analysis. Left, of 181 proteins identified by at least two peptides in
Analysis 1 (green circle), 82% were also identified by at least two
peptides in Analysis 2 (dark blue circle), 11% were identified by only
one peptide in Analysis 2 (light blue circle), and 7% were not recov-
ered in Analysis 2. Right, same as left, except that the diagram
indicates the percentage of the 176 proteins from Analysis 2 (two
peptide hits) that were identified at various levels of stringency in
Analysis 1. C, pairwise analysis of the different samples (wild type and
rpn10). The percentage of proteins from one analysis (row) present
in another analysis (column) is indicated. For each analysis, the num-
ber of identified proteins is shown in parentheses.
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most likely were not enriched in the two-step purification, as
is the case for free (i.e. not substrate-linked) mono-, di-, and
triubiquitin (Fig. 2B). Vhs2 protein level was also found unal-
tered in rpn10 cells (despite its relative low abundance), but
ubiquitylated Vhs2 was detected after IMAC of extracts from
rpn10 cells that expressed H8-ubiquitin (Fig. 4C).
DISCUSSION
In this article, we describe a new approach to the purifica-
tion and analysis of ubiquitin conjugates in the budding yeast
S. cerevisiae. Our approach involves two affinity purification
steps. The first step selects for ubiquitin chains that were able
to bind recombinant UBA domain-containing proteins and
thus were most likely competent to support degradation of
attached proteins. In the second step, ubiquitin conjugates
that contain H6-ubiquitin were enriched by IMAC. Conjugates
that survived the two enrichment steps were digested to yield
peptides, which were separated by multidimensional chroma-
tography and sequenced by MS/MS. This protocol enabled us
to identify a collection of candidate ubiquitin-conjugated pro-
teasome substrates. By performing a “subtractive” compari-
son of conjugates recovered from wild-type cells versus
rpn10 cells that lack the proteasome substrate receptor
Rpn10, we were able to identify a collection of proteins that
accumulate selectively in rpn10 and thus are candidate li-
gands for Rpn10. This effort revealed that the pool of candi-
date Rpn10 ligands is much larger than appreciated previ-
ously from one-off analyses.
The approach described here differs from prior “proteome-
wide” analyses of ubiquitin- (33, 34) and SUMO-conjugated
proteins (39–44) in several important respects. First, we pres-
ent data on replicate analyses. We found modest variation
(17%) in duplicate MS analyses of a single sample, but
significant variations (30%) when the entire affinity purifica-
tion and LC/LC-MS/MS analysis were repeated. Performing
replicate analyses is thus of considerable importance when
comparing the ubiquitin conjugate proteome in different
strains (e.g. wild type and rpn10) to ensure that any differ-
ences seen are due to the mutation under study and are not
simply a product of experimental variability. Performing rep-
licate experiments also helps to ensure that an analysis is as
thorough as possible. For example, some candidates that
TABLE II
Putative ubiquitylated proteins identified in rpn10 but not wild-type cells (54)
Proteins listed were identified (by a minimum of two valid peptides) in any of three independent analyses of rpn10 cells (A, B, and C) but
not in any of the three independent analyses of control cells (RPN10). Sequence coverage is indicated in percentages for A, B, and C analyses
and in the total column (corresponding to the sum of sequence coverage in the three experiments). The final validation status ( or –) for Rpn10
targets is indicated in the first column. The score for the increase of protein level in rpn10 and the presence of ubiquitylated species detected
after IMAC in rpn10 are indicated in the middle and last column, respectively. NT, not tested; 0, not validated; 1, validated; 2, ubiquitylated
species were detected in both rpn10 and RPN10 cells.
Name A B C Total Validation Name A B C Total Validation
GCN4 22.4 22.4 32.4 35.9  1 1 RPL16B 8.1 8.1
SIC1 32 32  1 1 VTS1 7.5 7.5
VMA2 24.2 24.2 CPA1 7.5 7.5 – 0 2
PUP3 23.9 23.9 YLL012W 7.2 7.2
YJR014W 23.2 23.2 – 0 0 FET3 6.8 6.8 – 0 NT
VHS2 17.2 9.6 22.9  0 1 LEU1 6.7 6.7
RPL13A, B 22.6 22.6  0 1 MCH4 6.4 6.4
LYS20 22.4 22.4 PPQ1 5.6 5.6
RPS29A, B 19.6 19.6 VPS72 4.9 4.9 – 0 2
LYS21 19.5 19.5 LYS2 3.6 3.2 4.8
PCL1 12.2 12.2 12.5 18.6 SGV1 4.7 4.7
SEL1 17.6 17.6 ERG3 4.4 4.4
RPL20A, B 16.3 16.3 MBP1 4.2 4.2 – 0 NT
RPL17A, B 15.8 15.8 REB1 4.1 4.1  1 NT
ARO10 7.7 3.3 6 15.3  1 2 ILV2 3.9 3.9
NOG2 14.8 14.8 NSP1 3.9 3.9 – 0 0
TUB1 13.4 13.4 TUB2 3.3 3.3
TOM22 13.2 13.2 13.2 YOR112W 3 3
GAT2 10.5 3.8 12.3 SHQ1 2.8 2.8
RTS3 11.4 11.4 ECM21 2.7 2.7  1 NT
DDR48 11.2 11.2 SIR4 2.7 2.7
TSR1 5.7 4.6 10.3 – 0 0 CHS7 2.5 2.5
ALK1 10 10 STP1 1.9 1.9 1.9
UBX7 9.6 9.6 CDC39 1.9 1.9
SSF2 9.5 9.5 MLP1 1.7 1.7  1 NT
NIP1 9.2 9.2 PSK2 1.1 1.1  1 NT
ALD6 2.4 8.6 8.6 MDN1 0.3 0.3  1 NT
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were validated (e.g. Sic1) were only identified in one of three
analyses. Indeed, of the candidates for which identification
was least robust (Mlp1, Psk2, and Mdn1, each of which was
found in only one analysis at 2% sequence coverage), all
three were validated as being responsive to Rpn10 function.
Thus, we strongly recommend that multidimensional analyses
be performed with replicate samples both to minimize false
positives and to enhance identification of target proteins.
A second key difference is that we employed a “functional”
affinity purification step in tandem with a tag-dependent af-
finity purification step. By comparison, Gygi and co-workers
(33, 34) employed a single nickel-nitrilotriacetic acid affinity
purification step in their analyses of the ubiquitin proteome.
The inclusion of a second, function-based affinity step had
two important consequences; first, it enabled superior enrich-
ment for ubiquitin-conjugated proteins, and second, it fo-
cused our analysis on a particular subset of ubiquitin-conju-
gated proteins (i.e. those that are candidate substrates for the
proteasome). In our hands, single-step purification with H6-
ubiquitin led to a relatively modest enrichment of ubiquitin
conjugates (100- to 200-fold)2 as compared with the two-step
purification (3,000- to 5,000-fold). This is in keeping with our
experience that 0.5% of total yeast extract proteins bind
specifically to IMAC resins. Thus, it is possible that a fair
fraction of the proteins identified previously are not bona fide
UPS substrates. Importantly, our approach has permitted the
identification of even the extremely inabundant UPS substrate
Gcn4, which is present at less than 50 molecules per cell (38).
Consistent with the greater degree of target focus intrinsic to
our analysis, we did not identify proteins that are known to be
conjugated with a single ubiquitin (e.g. histone H2A, B), nor
did we enrich for mono-, di-, or triubiquitin chains (Fig. 2B).
Finally, when we searched for peptides of ubiquitin itself that
carried the Gly-Gly signature, Lys48 was found to be the most
prominent conjugation site that was recovered (data not
shown). Lys29, Lys33, and Lys6 were more rarely identified,
and modified Lys63 was not found. These findings suggest
that we have established a new approach to identify specifi-
cally those proteins that are polyubiquitylated substrates of
the proteasome. In the future, other ubiquitin receptors, like
proteins containing UIM domains that bind mono-ubiquity-
lated targets in the endocytic pathway (e.g. Vps27 and Ent1)
FIG. 4. Analysis of candidate substrates of the Rpn10-dependent targeting pathway. A, proteins whose level was increased in rpn10.
The chromosomal locus for each candidate investigated was modified to introduce a TAP epitope tag fused to the carboxyl terminus of the
encoded protein. For each TAP-tagged candidate shown, equal amounts of proteins from RPN10 (wild type) and rpn10 () cells were
fractionated by SDS-PAGE on a 10% polyacrylamide gel and transferred to nitrocellulose. Immunoblotting was performed with anti-calmodulin
binding peptide antibody that recognizes the TAP tag and anti-Cdc28 (which served as a loading control). The caret highlights a novel species
of Ecm29 that was detected only in rpn10. B, ubiquitylated Gcn4 accumulates in rpn10. Equal amounts of proteins from RPN10 GCN4myc9
and rpn10 GCN4myc9 cells were separated by SDS-PAGE on a 10% polyacrylamide gel and transferred to nitrocellulose. Gcn4-Myc9 was
detected using the 9E10 antibody. C, purification of proteins conjugated to H8-ubiquitin. Proteins from strains with the indicated genotypes that
bound nickel beads in buffer containing 8 M urea plus 0.1% SDS were loaded onto a 10% polyacrylamide gel and subjected to SDS-PAGE
followed by immunoblotting with anti-calmodulin binding peptide antibody.
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or ZnF domains that bind selectively to Lys63-linked ubiquitin
chains (45), may be used to identify factors in nonproteasomal
pathways that are regulated allosterically by ubiquitylation.
Of the more than 120 proteins that we implicated as sub-
strates of the UPS, most function in translational and meta-
bolic pathways, and half of the candidates have high codon
adaptation index values (0.4).3 Many ribosomal proteins
were identified including some that were shown previously to
be ubiquitylated, like Rpl28, Rps3, and Rps20 (33, 46). Be-
cause ribosomes are highly abundant and formed by tight
macromolecular interactions, we cannot exclude that some of
the identified proteins were contaminants. However, it is also
possible that some of these candidate substrates might rep-
resent biosynthetic intermediates that fail to fold or assemble
properly, resulting in their rapid degradation either during or
shortly following the completion of translation (47, 48). In the
latter case, one would predict that the UPS might have little
impact on the total level of the candidate protein and that only
a very small fraction of the total protein pool in the cell is
ubiquitylated (depending on the fraction of the protein that
misfolds or misassembles). This is exactly what we observed
for Rpl13B. If a small fraction of Rpl13B fails to assemble
properly and is degraded rapidly by the UPS, it could help to
explain the presence of many proteins with high codon ad-
aptation index values in our analysis. Thus, the bulk of pro-
teins degraded by the proteasome in yeast cells might corre-
spond to misfolded, damaged, or improperly translated
proteins rather than proteins such as cyclins, CDK inhibitors,
and transcription factors whose functions are regulated by
proteolysis. Further studies will be required to address the
important issue of substrate flux through the UPS in yeast.
Notably, our method provides a means to identify substrates
of the chaperone pathways that enable efficient protein fold-
ing and assembly as well as the ubiquitin ligases that target
misfolded proteins for degradation by the UPS.
To gain a sense of the quality of our subtractive dataset of
conjugates uniquely found in rpn10 samples, we employed
two different assays to evaluate 17 of the 54 candidate Rpn10
substrates. The first and simplest assay was to compare by
immunoblotting the level of the candidate protein in wild-type
and rpn10 cells on the assumption that Rpn10 substrates
might accumulate to a higher level in rpn10. However, we
recognized that there may be substrates for which only a
small fraction of the total pool is degraded by an Rpn10-de-
pendent pathway, and these substrates might fail this test.
Thus, we devised a second assay that measured the level of
ubiquitylated candidate protein that was present in wild-type
and rpn10 cells. This second assay allowed us to confirm
some candidate proteins (e.g. Rpl13) that were not validated
by the first assay. Ultimately, we were able to confirm that
nearly 60% (10 of 17) of the candidates analyzed are respon-
sive to Rpn10 function. It is important to note that the valida-
tion experiments were done with TAP-tagged chromosomal
loci (which are in the S288C genetic background), and that the
cells were grown in synthetic medium to select for a H8-
ubiquitin expression plasmid. By contrast, the affinity purifi-
cation-mass spec analyses were performed with cells of the
W303 strain background grown in rich (YPD) medium. Thus, a
failure to confirm a candidate should not be construed as
definitive evidence that the candidate is not an Rpn10 ligand.
Nevertheless, the apparent high rate of false positives under-
scores that it is critical to carry out secondary analyses to
confirm data acquired in multidimensional MS analyses. Fu-
ture developments, including the implementation of quantifi-
cation methods and higher stringency biochemical separa-
tions, may reduce the experimental variations and false
positive rate.
A previous study (17) from this laboratory revealed that the
proteasome substrate receptors Rpn10 and Rad23 can pro-
mote degradation of specific subsets of UPS targets and
suggested that Rpn10 targets might be restricted to a small
class of UPS substrates. However, that study was based on
the piecemeal examination of a handful of UPS targets, and it
was not designed to reveal the full spectrum of substrates
targeted to the proteasome by a given ubiquitin chain recep-
tor. By using the two-step purification multidimensional MS
method described here, we have identified several dozen
candidate ligands for an Rpn10-dependent targeting pathway
that function in a broad range of processes including metab-
olism, transcription, translation, nuclear transport, and cell
cycle. By applying this approach to mutants lacking other
receptors (e.g. rad23, dsk2), it should be feasible to begin
the task of constructing a “linkage map” that reveals the
spectrum of substrates that are targeted to the proteasome
by a specific receptor, which may in turn provide insight into
the mechanisms that underlie the allocation of ubiquitylated
substrates to different receptor pathways.
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